ES2173372T3 - Comprimidos multicapa que contienen microorganismos probioticos, como por ejemplo latobacilos o bifidobacterias. - Google Patents

Comprimidos multicapa que contienen microorganismos probioticos, como por ejemplo latobacilos o bifidobacterias.

Info

Publication number
ES2173372T3
ES2173372T3 ES97122492T ES97122492T ES2173372T3 ES 2173372 T3 ES2173372 T3 ES 2173372T3 ES 97122492 T ES97122492 T ES 97122492T ES 97122492 T ES97122492 T ES 97122492T ES 2173372 T3 ES2173372 T3 ES 2173372T3
Authority
ES
Spain
Prior art keywords
latobacilos
bifidobacteria
examples
probiotic microorganisms
containing probiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97122492T
Other languages
English (en)
Inventor
Martino Fusca
Dagmar Farber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Application granted granted Critical
Publication of ES2173372T3 publication Critical patent/ES2173372T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/20—Agglomerating; Granulating; Tabletting
    • A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • General Preparation And Processing Of Foods (AREA)

Abstract

LA INVENCION TRATA DE TABLETAS PLURIESTRATIFICADAS, QUE ESTAN FORMADAS DE DOS, TRES O MAS CAPAS, CONTENIENDO UNA CAPA MICROORGANISMOS PROBIOTICOS, MIENTRAS QUE LAS OTRAS CAPAS CONTIENEN SUSTANCIAS ALIMENTICIAS MUY NUTRITIVAS, COMO VITAMINAS, MINERALES, ETC. LAS TABLETAS SE CARACTERIZAN, EN RELACION CON LOS MICROORGANISMOS UTILIZADOS, POR UNA ELEVADA ESTABILIDAD O ACCION EN UN AMPLIO ESPACIO DE TIEMPO, Y POR TANTO SON APROPIADAS PARA CONSERVARSE EN ALMACENAMIENTO.
ES97122492T 1997-12-19 1997-12-19 Comprimidos multicapa que contienen microorganismos probioticos, como por ejemplo latobacilos o bifidobacterias. Expired - Lifetime ES2173372T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97122492A EP0931543B1 (de) 1997-12-19 1997-12-19 Mehrschichttablette enthaltend probiotische Mikroorganismen wie z.B. Lactobacilli oder Bifidobakterien

Publications (1)

Publication Number Publication Date
ES2173372T3 true ES2173372T3 (es) 2002-10-16

Family

ID=8227836

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97122492T Expired - Lifetime ES2173372T3 (es) 1997-12-19 1997-12-19 Comprimidos multicapa que contienen microorganismos probioticos, como por ejemplo latobacilos o bifidobacterias.

Country Status (10)

Country Link
US (1) US6254886B1 (es)
EP (1) EP0931543B1 (es)
JP (1) JP3844597B2 (es)
AT (1) ATE214597T1 (es)
CA (1) CA2242107C (es)
DE (2) DE59706697D1 (es)
DK (1) DK0931543T3 (es)
ES (1) ES2173372T3 (es)
PT (1) PT931543E (es)
SI (1) SI0931543T1 (es)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6406692B1 (en) * 1997-10-31 2002-06-18 New Horizons Diagnostics Corp Composition for treatment of an ocular bacterial infection
NL1010770C2 (nl) * 1998-12-09 2000-06-13 Nutricia Nv Preparaat dat oligosacchariden en probiotica bevat.
SE515310C2 (sv) 1999-11-25 2001-07-09 Wasa Medicals Ab Tabletter innehållande mikroorganismer och förfarande för framställning därav
DE10008279A1 (de) * 2000-02-23 2001-08-30 Meggle Gmbh Milchzucker enthaltende Zusammensetzung
US6592863B2 (en) * 2000-08-22 2003-07-15 Nestec S.A. Nutritional composition
EP1228769A1 (de) * 2001-02-02 2002-08-07 Jörg-Peter Prof. Schür Symbiontisches Regenerativum
KR100483080B1 (ko) * 2001-09-21 2005-04-14 한인규 염산·베타인(betaine·HCl), 판크레아틴, 제2인산 칼슘, 크롬 피콜리네이트, 락토바실러스속·비피도박테리아속·스트렙토코커스속·프럭토 올리고당, 비타민, 미네랄을 유효성분으로 구성된 것을 특징으로 하는 증체개선용 영양강화 사료첨가제
US20040052852A1 (en) * 2001-09-25 2004-03-18 Michael Farber Carbohydrate-based delivery system for creatine and other bioactive ingredients
US20040052843A1 (en) * 2001-12-24 2004-03-18 Lerner E. Itzhak Controlled release dosage forms
US7101565B2 (en) 2002-02-05 2006-09-05 Corpak Medsystems, Inc. Probiotic/prebiotic composition and delivery method
DE10206995B4 (de) * 2002-02-19 2014-01-02 Orthomol Pharmazeutische Vertriebs Gmbh Mikronährstoffkombinationsprodukt mit Pro- und Prebiotika
JP2005526038A (ja) * 2002-02-21 2005-09-02 ソシエテ デ プロデユイ ネツスル ソシエテ アノニム 皮膚の光防護のための経口投与可能な組成物
UA78547C2 (en) * 2002-02-21 2007-04-10 Nestle Sa Light-protective composition for skin intended for oral administration
EP1492508A4 (en) * 2002-03-04 2009-05-06 Teva Pharma DOSAGE FORMS WITH CONTROLLED RELEASE
EP1344458A1 (en) * 2002-03-12 2003-09-17 Société des Produits Nestlé S.A. Probiotic delivery system
US6663892B1 (en) 2002-08-19 2003-12-16 L. Perrigo Company Multiple portion tablet
ITBO20020564A1 (it) * 2002-09-06 2004-03-07 Alfa Wassermann Spa Bifidobatteri e preparazioni che li contengono.
US20050266069A1 (en) * 2002-09-06 2005-12-01 Simmons Donald L Stable probiotic microsphere compositions and their methods of preparation
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
GB0330009D0 (en) * 2003-12-24 2004-01-28 Ferrosan As Probiotic tablet formulations
US20080160086A1 (en) * 2004-02-19 2008-07-03 Scepter Holdings, Inc. Delivery Systems For Calcium
MXPA06015184A (es) * 2004-06-23 2007-11-22 Nestec Sa Procedimiento y composiciones utiles para prevenir y/o tratar pieles sensibles y/o secas.
FR2872047B1 (fr) * 2004-06-23 2007-06-15 Oreal Composition pour peaux sensibles associant cation mineral et probiotique(s)
BRPI0516437A (pt) * 2004-10-04 2008-09-02 Oreal E Nestec S A L utilização de uma quantidade eficaz de pelo menos um microorganismo, processo de tratamento cosmético, composição cosmética e/ou dermatológica e composição para absorção oral
US8858960B2 (en) * 2004-11-19 2014-10-14 GlaxoSmithKline, LLC Method of producing a pharmaceutical product
US20100233312A9 (en) * 2005-04-11 2010-09-16 The Procter & Gamble Company Compositions comprising probiotic and sweetener components
AU2006253007B2 (en) 2005-05-31 2012-12-20 Alimentary Health Ltd Feline probiotic Bifidobacteria
EP2261323A1 (en) 2005-05-31 2010-12-15 The Iams Company Feline probiotic lactobacilli
US7297679B2 (en) * 2005-07-13 2007-11-20 Allergan, Inc. Cyclosporin compositions
FR2889057B1 (fr) * 2005-08-01 2008-07-18 Oreal Composition cosmetique et/ou dermatologique pour la prevention et/ou le traitement des peaux sensibles ou seches
CA2623968C (en) * 2005-09-29 2014-12-09 Merck Patent Gesellschaft Mit Beschraenkter Haftung Method for stabilising pharmaceutical administration forms comprising microorganisms
US8691272B2 (en) * 2005-12-30 2014-04-08 Intelgenx Corp. Multilayer tablet
US20080260906A1 (en) * 2006-03-17 2008-10-23 Marko Stojanovic Compositions comprising probiotic and sweetener components
KR101470483B1 (ko) * 2006-03-24 2014-12-08 코와 가부시키가이샤 구강내 신속 붕괴성 정제
US20100316769A1 (en) * 2006-03-29 2010-12-16 Gail Czarnecki-Maulden Dietary supplements containing probiotics
US20070251352A1 (en) 2006-05-01 2007-11-01 Pruitt Judith G Pelletized Feed Material for Biomass Generator
WO2008013536A2 (en) * 2006-07-26 2008-01-31 Sensient Flavors Inc. Food products comprising probiotic microorganisms and methods of preparation
US9084434B2 (en) 2006-09-27 2015-07-21 Little Calumet Holdings Llc Probiotic oral dosage forms
KR20090088913A (ko) 2006-11-21 2009-08-20 맥네일-피피씨, 인코포레이티드 개질된 방출형 진통 현탁제
RU2436581C2 (ru) 2007-02-01 2011-12-20 Дзе Иамс Компани Способ уменьшения воспаления и снижения стресса у млекопитающего
US20080254119A1 (en) * 2007-04-16 2008-10-16 Wyeth Imbedded liquid lubricants for tableting
TWI400042B (zh) * 2007-06-08 2013-07-01 Tci Co Ltd 食品錠劑
US9833510B2 (en) * 2007-06-12 2017-12-05 Johnson & Johnson Consumer Inc. Modified release solid or semi-solid dosage forms
FR2919501B1 (fr) * 2007-08-02 2010-12-31 Oreal Utilisation d'hesperidine ou de l'un de ses derives pour la prevention et/ou le traitement des peaux relachees
FR2920305B1 (fr) 2007-09-04 2010-07-30 Oreal Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles.
CA2697735C (en) * 2007-09-04 2014-02-18 L'oreal Use of a combination of hesperidin and of a microorganism for influencing the barrier function of the skin
FR2920304B1 (fr) * 2007-09-04 2010-06-25 Oreal Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse.
US20090087525A1 (en) * 2007-09-28 2009-04-02 Ogushi Kinsen Manufacturing of polysaccharide based nutritional supplement
US9771199B2 (en) * 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
FR2942719B1 (fr) 2009-03-04 2011-08-19 Oreal Utilisation de microorganismes probiotiques pour limiter les irritations cutanees
WO2010114864A1 (en) * 2009-04-01 2010-10-07 Little Calumet Holdings, Llc Probiotic oral dosage forms
US8551762B2 (en) 2009-07-07 2013-10-08 Nch Corporation System and apparatus for feeding, solubilizing, growing and discharging a biological material
US8961893B2 (en) * 2009-07-07 2015-02-24 Nch Corporation Automated chemical diluter system having disposable components
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
JP2013507394A (ja) * 2009-10-09 2013-03-04 プロセラ インコーポレイテッド 自閉症スペクトル障害と診断されたヒトにおいて自閉症スペクトル障害に関連する少なくとも一つの症状を低減するための、ペディオコッカス属を含む組成物及び方法
JP2013510560A (ja) * 2009-11-13 2013-03-28 ユニストロー パテント ホールディングス リミテッド プロバイオティック組成物、並びにプロバイオティック組成物を投与する方法及び器具
US20110136815A1 (en) * 2009-12-08 2011-06-09 Horst Zerbe Solid oral film dosage forms and methods for making same
US10610528B2 (en) 2009-12-08 2020-04-07 Intelgenx Corp. Solid oral film dosage forms and methods for making same
MA40071A (fr) * 2014-07-01 2016-01-07 Probi Usa Inc Comprimés probiotiques bi-couche à double libération
JP6938824B2 (ja) * 2016-03-15 2021-09-22 ディーエスエム アイピー アセッツ ビー．ブイ．Ｄｓｍ Ｉｐ Ａｓｓｅｔｓ Ｂ．Ｖ． 被覆された粒子
US10323226B2 (en) 2017-03-30 2019-06-18 Nch Corporation Feed material for biomass generator
WO2020181096A1 (en) * 2019-03-05 2020-09-10 The Texas A&M University System Combinations of tannase and probiotic formulations and methods of use for improving tannin metabolism
CN116420788A (zh) * 2023-02-23 2023-07-14 北京态蓝科技有限公司 一种含有复合益生菌的含片及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60221078A (ja) * 1984-04-18 1985-11-05 Morinaga Milk Ind Co Ltd 有用微生物粉末の粒状製品およびその製造法
US4806368A (en) * 1987-09-16 1989-02-21 Reddy Malireddy S Shelf life and subsequent growth of lactobacillus acidophilus, propionibacterium shermanii and leuconostoc citrovorum in dietary fiber based supplement preparation
US5705152A (en) * 1990-10-26 1998-01-06 Interprise Limited Antimicrobial composition
US5275943A (en) * 1991-04-12 1994-01-04 Dituro John W Timed-release tablets for biological degradation of organic matter
JPH05186337A (ja) * 1992-01-09 1993-07-27 Kanebo Ltd 腸溶性複粒造粒物
US5531989A (en) * 1994-10-28 1996-07-02 Metagenics, Inc. Immunoglobulin and fiber-containing composition for human gastrointestinal health
JP3024496B2 (ja) * 1994-11-22 2000-03-21 田辺製薬株式会社 腸内有用細菌含有錠剤

Also Published As

Publication number Publication date
SI0931543T1 (en) 2002-10-31
PT931543E (pt) 2002-09-30
DK0931543T3 (da) 2002-06-17
JP3844597B2 (ja) 2006-11-15
DE19830528A1 (de) 1999-07-01
EP0931543B1 (de) 2002-03-20
ATE214597T1 (de) 2002-04-15
US6254886B1 (en) 2001-07-03
JPH11199496A (ja) 1999-07-27
EP0931543A1 (de) 1999-07-28
DE59706697D1 (de) 2002-04-25
CA2242107A1 (en) 1999-06-19
CA2242107C (en) 2011-10-11

Similar Documents

Publication Publication Date Title
ES2173372T3 (es) Comprimidos multicapa que contienen microorganismos probioticos, como por ejemplo latobacilos o bifidobacterias.
ES2175442T3 (es) Composiciones de carbohidratos de plantas como complementos dieteticos
JPH11199496A5 (es)
EA200601214A1 (ru) Композиции пробиотической таблетки
DE59910308D1 (de) Alpha-amylase-resistente stärke zur herstellung von nahrungs- und arzneimitteln
AR031283A1 (es) Composicion y metodo de dieta para animales
CO5540276A2 (es) Suplemento liquido oral caloricamente denso
IL186788A0 (en) Nutritional supplement for hiv patients
MXPA04005993A (es) Producto alimenticio que contiene capsulas o tabletas de gel.
DE60139995D1 (de) Tryptophansquelle aus pflanzen und deren verwendungen
WO2001091770A3 (en) Compositions for treating eye discomfort containing herbals and/or nutritional supplements and/or minerals and/or vitamins
ES2168849T3 (es) Producto alimenticio formulado, con humedad reducida.
ES2195902T3 (es) Composicion que comprende esfingomielinasa alcalina para uso como preparacion dietetica, complemento alimenticio o producto farmaceutico.
WO2001091767A3 (en) Compositions for enhancing therapeutic effects containing herbals and/or nutritional supplements and/or minerals and/or vitamins
GB2438574A (en) Nutritionally balanced food or beverage product
ATE290772T1 (de) Lebensmittelbehälter
WO2002089741A3 (en) Compositions and methods for enhancing drug delivery
KR970000073A (ko) 다이어트 영양 조성물
WO2003053163A3 (fr) Composition de sel pauvre en chlorure de sodium et riche en sel organique de potassium et ses utilisations
WO2001091766A3 (en) Compositions for treating hand and wrist discomfort containing herbals and/or nutritional supplements and/or minerals and/or vitamins
WO2001091771A3 (en) Compositions for treating back and leg discomfort containing herbals and/or nutritional supplements and/or minerals and/or vitamins
KR20230100520A (ko) 닭가슴살육포
WO2001091778A3 (en) Compositions for treating neck and shoulder discomfort containing herbals and/or nutritional supplements and/or minerals and/or vitamins
Dickinson Nutritional Supplements: Integral Components of a Healthy Lifestyle
BR8302061U (pt) Configuração aplicada em embalagem para alimentos

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 931543

Country of ref document: ES